Wei Liu | Innovation in Data Analysis | Best Researcher Award

Posted on by Research Data Analysis

Prof. Wei Liu | Innovation in Data Analysis | Best Researcher Award

Peking University First Hospital | China

Profile Verified

orcid

🧬 Summary

Dr. Wei Liu. is a distinguished expert in Medical Mycology and Dermatology, currently serving as a Professor, Researcher, and Physician at Peking University First Hospital. With over two decades of clinical, academic, and research experience, Dr. Liu has significantly contributed to the understanding of fungal pathogenesis, antifungal drug resistance, and dermatological infections. Her work has led to numerous high-impact publications and national research grants, making her a leading figure in the field.

🎓 Education

Dr. Liu earned her Bachelor’s degree in Clinical Medicine (1993) and Master’s in Dermatology (1998) from Lanzhou Medical College, followed by a Ph.D. in Medical Mycology and Dermatology from Peking University in 2001.

🏥 Professional Experience

Dr. Liu has held progressive roles at Peking University First Hospital since 2004, currently holding positions as Professor (since 2013), Researcher (since 2012), and Physician (since 2004) in the Department of Dermatology and Medical Mycology. She previously completed a postdoctoral fellowship at the University of Texas MD Anderson Cancer Center (2002–2004), focusing on fungal infections in immunocompromised patients.

📚 Academic Citations

Dr. Liu has co-authored numerous peer-reviewed papers in prominent journals such as Antimicrobial Agents and Chemotherapy, Frontiers in Microbiology, and Antibiotics. Her research on antifungal resistance mechanisms in Candida and Aspergillus species has been widely cited and recognized for its clinical relevance.

🛠️ Technical Skills

Dr. Liu is proficient in molecular biology techniques, drug-resistance profiling, fungal genomics, clinical diagnostics, and antifungal susceptibility testing. Her expertise also includes establishing resistance monitoring platforms using omics data.

👩‍🏫 Teaching Experience

As a long-standing faculty member at Peking University, Dr. Liu has mentored medical students, dermatology residents, and Ph.D. candidates in clinical mycology, infectious dermatology, and laboratory research methods, contributing significantly to academic development in her department.

🔬 Research Interests

Her current research focuses on the molecular evolution of drug resistance in pathogenic fungi, especially Candida and Aspergillus species; host-pathogen interactions; and the development of novel diagnostic and therapeutic strategies for drug-resistant fungal infections.

📚 Selected Publication

Point Mutation or Overexpression of Aspergillus fumigatus cyp51B, Encoding Lanosterol 14α-Sterol Demethylase, Leads to Triazole Resistance

  • Authors: Mariana Handelman, Zohar Meir, Jennifer Scott, Yona Shadkchan, Wei Liu, Ronen Ben-Ami, Jorge Amich, Nir Osherov

  • Journal: Antimicrobial Agents and Chemotherapy

  • Year: 2021

Triazole-Resistant Aspergillus fumigatus in an Israeli Patient with Chronic Cavitary Pulmonary Aspergillosis Due to a Novel E306K Substitution in Hmg1

  • Authors: Mariana Handelman, Alma Morogovsky, Wei Liu, Ronen Ben-Ami, Nir Osherov

  • Journal: Antimicrobial Agents and Chemotherapy

  • Year: 2021

Emergence of W272C Substitution in Hmg1 in a Triazole-Resistant Isolate of Aspergillus fumigatus from a Chinese Patient with Chronic Cavitary Pulmonary Aspergillosis

  • Authors: Tianyu Liang, Xinyu Yang, Ruoyu Li, Ence Yang, Qiqi Wang, Nir Osherov, Wei Chen, Zhe Wan, Wei Liu

  • Journal: Antimicrobial Agents and Chemotherapy

  • Year: 2021

Gilles-eric Seralini | Environmental Data Analysis | Lifetime achievement Award

Posted on by Research Data Analysis

Prof. Gilles-eric Seralini | Environmental Data Analysis | Lifetime achievement Award

University Of Caen Normandy – Mrsh | France

PUBLICATION PROFILE

Google Scholar

📌 INTRODUCTION

Prof. Gilles-Éric Séralini, born on August 23, 1960 in Bône, Algeria (then under French rule), is a prominent French molecular biologist known for his pioneering work on genetically modified organisms (GMOs), endocrine disruptors, and environmental toxicology. Holding French nationality, he has built a distinguished academic and scientific career centered on public health, molecular biology, and scientific integrity. He is especially recognized for his commitment to independent research in the face of industrial and political pressures.

🎓 EARLY ACADEMIC PURSUITS

Séralini embarked on his academic journey in France, earning his Baccalauréat D in 1977 before progressing to higher studies in biology and biochemistry at Université de Nice and Université de Montpellier II. He obtained a DEA in Endocrinology and Development in 1983 as the major of his class, followed by a Ph.D. in Biochemistry and Molecular Biology in 1987, with a thesis focused on the effects of alpha-fetoprotein on reproductive health in rats. His postdoctoral studies took him to Canada, where he worked at the University of Western Ontario (1987–1989) and later at the CHU of Laval University in Quebec (1990–1991). He completed his Habilitation à Diriger des Recherches (HDR) in 1991 at the Université de Caen, marking the start of his supervisory and research leadership career.

👨‍🏫 PROFESSIONAL ENDEAVORS

Since October 1991, Prof. Séralini has served as a Professor of Molecular Biology at the Université de Caen, where he achieved the classe exceptionnelle, the highest academic title in French higher education. At Caen, he has led research in endocrinology, toxicology, and GMO risk assessment. He co-founded two major organizations: CRIIGEN (Committee for Independent Research and Information on Genetic Engineering) in 1999 and ENSSER (European Network of Scientists for Social and Environmental Responsibility), both advocating for unbiased scientific research and environmental responsibility. He has also supervised numerous Ph.D. theses, mentored young researchers, and secured major research grants.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

Prof. Séralini’s research emphasizes the molecular and physiological impacts of environmental pollutants, especially GMOs and glyphosate-based herbicides. He has gained international recognition for conducting long-term toxicity studies on rats, demonstrating tumor development and organ damage due to prolonged glyphosate exposure—studies that sparked major debates worldwide. His work often critiques the methodologies used by regulatory agencies and calls for increased transparency and independence in science. Additionally, he has developed improved testing standards for chemical exposure and actively promotes public awareness through books and media.

🌍 IMPACT AND INFLUENCE

Séralini has significantly shaped global discussions around agrochemical safety, regulatory science, and science ethics. He has been consulted by the European Commission, EFSA, and various French ministries, and has provided expert testimony in several high-profile legal cases involving GMOs. His advocacy efforts have contributed to a broader awareness of environmental health risks and have called attention to the importance of scientific integrity in public policy. Despite facing strong opposition from industrial stakeholders, his work has inspired a global movement for ethical and independent research.

📚 ACADEMIC CITATIONS AND PUBLICATIONS

Over the decades, Prof. Séralini has authored more than 100 peer-reviewed articles, contributed to scientific books, and delivered numerous seminars and invited talks internationally. His research is frequently cited in the fields of molecular biology, toxicology, environmental health, and regulatory science. He also holds a patent and has participated in international and national conferences, further extending his academic impact.

🏆 HONORS & AWARDS

Prof. Séralini’s excellence and courage in scientific research have earned him numerous awards, including:

  • 🏅 Prix Philips (1998) for science communication

  • 🎖️ Ordre de l’Étoile de l’Europe (1999)

  • 🥇 Prix Denis Guichard (2001) from the Fondation de France

  • 🇫🇷 Chevalier de l’Ordre National du Mérite (2008)

  • 🛡️ International Whistleblower Award (2015, Germany)

  • 🌱 Théo Colborn Award (2016, USA) for environmental health

  • 👩‍👦 Healthy Communities Hero Award (2018) by Moms Across America

  • 🧬 Best Molecular Biology Academic (2023) by Healthcare and Pharmaceutical Awards

These recognitions celebrate both his scientific contributions and his enduring stand for public and planetary well-being.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Prof. Séralini’s legacy lies in his unyielding pursuit of truth and scientific responsibility. His work continues to influence environmental regulations, academic discussions on GMO transparency, and the ethics of scientific disclosure. By combining high-impact research with public education, he has shaped both policy and public understanding of environmental health. Looking ahead, he is expected to continue his research and advocacy, leaving a lasting imprint on science for society.

✍️ FINAL NOTE

Prof. Gilles-Éric Séralini embodies the role of the engaged scientist—one who not only contributes to molecular biology but also defends ethical, independent, and public-interest science. His career is a testament to the power of standing firm in the face of controversy for the greater good. Through research, teaching, and public outreach, he continues to champion a science that prioritizes human and ecological health above industrial interests.

 📚 TOP NOTES PUBLICATIONS

RETRACTED: Long term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize

    • Authors: GE Séralini, E Clair, R Mesnage, S Gress, N Defarge, M Malatesta, et al.

    • Journal: Food and Chemical Toxicology

    • Year: 2012

Differential effects of glyphosate and roundup on human placental cells and aromatase

    • Authors: S Richard, S Moslemi, H Sipahutar, N Benachour, GE Séralini

    • Journal: Environmental Health Perspectives

    • Year: 2005

Glyphosate-based herbicides are toxic and endocrine disruptors in human cell lines

    • Authors: C Gasnier, C Dumont, N Benachour, E Clair, MC Chagnon, GE Séralini

    • Journal: Toxicology

    • Year: 2009

Glyphosate formulations induce apoptosis and necrosis in human umbilical, embryonic, and placental cells

    • Authors: N Benachour, GE Séralini

    • Journal: Chemical Research in Toxicology

    • Year: 2009

Potential toxic effects of glyphosate and its commercial formulations below regulatory limits

    • Authors: R Mesnage, N Defarge, JS De Vendômois, GE Séralini

    • Journal: Food and Chemical Toxicology

    • Year: 2015

Ethoxylated adjuvants of glyphosate-based herbicides are active principles of human cell toxicity

    • Authors: R Mesnage, B Bernay, GE Séralini

    • Journal: Toxicology

    • Year: 2013

Ling Huang | Emerging Research Trends | Best Researcher Award

Posted on by Research Data Analysis

Prof. Ling Huang | Emerging Research Trends | Best Researcher Award

Nanjing Tech University | China

PUBLICATION PROFILE

Scopus

👨‍🔬 Summary

Prof. Ling Huang is a distinguished professor at Xinjiang University in China, specializing in Inorganic Chemistry, Rare Earth Chemistry, and Functional Materials. With over two decades of research and academic experience, his work focuses on areas such as rare earth luminescence, defect engineering, and advanced material applications. His expertise has led him to significant accolades, including being named a Fellow of the Royal Society of Chemistry (FRSC). Prof. Huang has also mentored numerous graduate students and postdoctoral researchers, leaving a lasting impact on the scientific community.

🎓 Education

Prof. Huang completed his Ph.D. in Inorganic Chemistry at Nanjing University (1996 – 2001) in China, following his B.Sc. in Chemistry from Jiangsu Normal University (1992 – 1996). His academic journey laid the foundation for his future research in chemistry and materials science.

💼 Professional Experience

Prof. Huang has held several prestigious positions throughout his career. He is currently a Professor at Xinjiang University (2021 – Present). Prior to this, he served as a professor at Nanjing Tech University (2012 – 2021), and as an associate professor at Nanyang Technological University in Singapore (2009 – 2012). His industry experience includes working as a Senior Research Scientist at Corning Inc., USA (2008 – 2009). Additionally, he has been a Post-Doctoral Research Associate at Northwestern University, Florida State University, and UC Berkeley, USA, where he honed his expertise in nanomaterials and rare earth chemistry.

📚 Academic Citations

Prof. Huang has authored over 180 publications, contributing significantly to the fields of luminescence and functional materials. Notable papers include “Abnormal But Rational: Luminescence Anti-Thermal Quenching in ScPO4:Er” and “Atomic Pr-Stabilized Pt Nanoclusters Accelerate Alkaline Hydrogen Evolution”, both of which are currently under review in prestigious journals such as Nature Communications and Angewandte Chemie.

🛠️ Technical Skills

Prof. Huang’s technical expertise covers a broad range of scientific fields. He is skilled in rare earth luminescence (upconversion/downshifting, anti-thermal quenching), material synthesis (creating functional ceramics, glasses, and solid-state electrolytes), and defect engineering (optimizing properties of materials through bandgap engineering and structural manipulation).

📖 Teaching Experience

Throughout his academic career, Prof. Huang has taught various courses at both the undergraduate and graduate levels. At Nanjing Tech University, he has taught courses such as Inorganic Chemistry, Luminescent Materials, and Advanced Nanomaterials (2014 – Present). Additionally, at Nanyang Technological University, he taught Bioelectronics, Chemistry I & II, and Biomedical Nanotechnology (2009 – 2012), shaping the education of future scientists and engineers.

🔬 Research Interests

Prof. Huang’s research interests lie at the intersection of rare earth chemistry and functional materials. He investigates luminescent materials, focusing on anti-thermal quenching and chiral luminescence. His research extends to functional materials, including solid-state fuel cells and optical devices, and solid-state chemistry, where he explores defect engineering to enhance the properties of materials for a variety of applications.

📚 Top Notes Publications 

Anti-thermal quenching upconversion luminescence of Cr3+ in Sc2(WO4)3:Yb/Cr

    • Authors: Yang Wei, Shuaihao Wu, Ran Chen, Yanqing Lu, Ling Huang

    • Journal: Nano Research

    • Year: 2025

Ultra-low temperature selective catalytic reduction of NOx into N2 by micron spherical CeMnOx in high-humidity atmospheres containing SO2

    • Authors: Xixi Chen, Peng Gao, Ling Huang, Zonghang Liu, Yuesong Shen

    • Journal: Applied Catalysis B: Environmental

    • Year: 2025

Orderly Stacked “Tile” Architecture with Single-Atom Iron Boosts Oxygen Reduction in Liquid and Solid-State Zn–Air Batteries

    • Authors: Bin Zhang, Jingshuang Dang, Hongyi Li, Ling Huang, Jingui Duan

    • Journal: Advanced Functional Materials

    • Year: 2025

RbB7O10(OH)2 and NaB11O16(OH)2: alkali metal hydroxyborates with two-dimensional layered structures and large birefringence

    • Authors: Yujing Zheng, Ke Li, Ling Huang, Fangfang Zhang

    • Journal: Dalton Transactions

    • Year: 2025

Regulating the Dynamics of Interpenetrated Porous Frameworks for Inverse C2H6/C2H4 Separation at Elevated Temperature

    • Authors: Kui Tan, Jingui Duan, Ling Huang

    • Journal: Angewandte Chemie International Edition in English

    • Year: 2025

Elżbieta Złowocka-Perłowska | kidney cancer | Best Researcher Award

Posted on by Research Data Analysis

Dr. Elżbieta Złowocka-Perłowska | kidney cancer | Best Researcher Award

Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University | Poland

PUBLICATION PROFILE

Orcid

Dr. Elżbieta Złowocka-Perłowska⚡🌍

INTRODUCTION 🌟

Dr. Elżbieta Złowocka-Perłowska is a distinguished academic and researcher at the Pomeranian Medical University, specializing in clinical genetics, molecular biology, and hereditary cancers. With over two decades of dedication to the Hereditary Cancer Center at the Department of Genetics and Pathomorphology, she has become an influential figure in medical sciences, particularly focusing on bladder and kidney cancer research. Her work aims to integrate trace element analysis into personalized cancer treatment models, contributing significantly to the field of molecular genetics.

EARLY ACADEMIC PURSUITS 🎓

Dr. Złowocka-Perłowska’s academic journey began with a diploma in Biology from the University of Szczecin in 2002. She then pursued a PhD in Medical Sciences at Pomeranian Medical Academy in Szczecin, where she earned her degree with distinction in 2008. Throughout her early academic years, she demonstrated a deep commitment to the study of genetics and its implications for cancer research.

PROFESSIONAL ENDEAVORS 💼

Since 2002, Dr. Złowocka-Perłowska has been associated with the Hereditary Cancer Center at the Pomeranian Medical University. Her career has evolved from a PhD student to a University Lecturer, Assistant Professor, and National Consultant in Clinical Genetics. She has taught both Polish and English-language courses across various medical and biotechnology programs. Dr. Złowocka-Perłowska’s professional endeavors have led her to direct research projects on cancer diagnostics, utilizing molecular techniques like MLPA, TaqMan, and NGS.

CONTRIBUTIONS AND RESEARCH FOCUS ON kidney cancer🔬

Dr. Złowocka-Perłowska’s research is centered on the study of hereditary cancers, particularly bladder and kidney cancers. Her current research project aims to explore the role of trace elements in cancer prognosis, with a specific focus on blood and serum selenium levels as potential markers for survival. She has conducted extensive studies using molecular genetics techniques and has made significant contributions to the understanding of hereditary cancer genetics. Her scientific work has culminated in 51 publications, four patents (including an international patent), and numerous conference presentations.

IMPACT AND INFLUENCE 🌍

As a recognized leader in the field of hereditary cancer research, Dr. Złowocka-Perłowska has had a profound impact on both medical education and healthcare. Her contributions to clinical studies, research, and the advancement of cancer treatments have been recognized internationally. Through her scientific publications and involvement in research projects, she continues to influence the development of personalized medicine and clinical genetics.

ACADEMIC CITATIONS AND PUBLICATIONS 📚

Dr. Złowocka-Perłowska is the author and co-author of numerous scientific papers published in national and international journals. Her work focuses on hereditary cancers and molecular biology, contributing to the advancement of clinical genetics. With 51 publications to her name, her research is frequently cited by peers in the scientific community. Her papers have been presented at several renowned scientific conferences, establishing her as a thought leader in her field.

HONORS & AWARDS 🏆

Dr. Złowocka-Perłowska has received numerous accolades throughout her career, including the Minister of Health’s Team Award in 2005 and the prestigious “Eminent Scientist of the Year 2009” award from the World Scientist Forum International Awards. She has also been honored with multiple Rector’s Awards for her scientific achievements at Pomeranian Medical University. Other recognitions include certifications for NGS sequencing training and contributions to laboratory medical genetics.

FINAL NOTE ✨

Dr. Złowocka-Perłowska’s work is a testament to the power of academic dedication and scientific inquiry. Her commitment to advancing medical genetics, particularly in the study of hereditary cancers, has significantly shaped the field. Through her research, teaching, and clinical contributions, she continues to inspire future generations of scientists and clinicians.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

Dr. Złowocka-Perłowska’s ongoing research on cancer treatment and prognostic markers positions her as a key figure in the evolution of personalized medicine. With her focus on integrating molecular techniques and trace element analysis, her future contributions will likely continue to revolutionize cancer diagnostics and treatment. She leaves a lasting legacy in the field of medical genetics, with a promising trajectory for further scientific discovery.

TOP NOTES PUBLICATIONS 📚

1. Blood and Serum Copper and Zinc Levels and 10-Year Survival of Patients After Kidney Cancer Diagnosis

  • Authors: Elżbieta Złowocka-Perłowska, Piotr Baszuk, Wojciech Marciniak, Róża Derkacz, Aleksandra Tołoczko-Grabarek, Katarzyna Gołębiewska, Marcin Słojewski, Adam Gołąb, Artur Lemiński, Michał Soczawa, et al.
  • Journal: Nutrients
  • Year: 2025
  • DOI: 10.3390/nu17060944

2. Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland

  • Authors: Elżbieta Złowocka-Perłowska, Aleksandra Tołoczko-Grabarek, Steven A. Narod, Jan Lubiński
  • Journal: Hereditary Cancer in Clinical Practice
  • Year: 2022
  • DOI: 10.1186/s13053-022-00220-6

3. Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in Polish population

  • Authors: Elżbieta Złowocka-Perłowska, Aleksandra Tołoczko-Grabarek, Jan Lubiński
  • Journal: Hereditary Cancer in Clinical Practice
  • Year: 2022
  • DOI: 10.1186/s13053-021-00208-8

4. Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population

  • Authors: Elżbieta Złowocka-Perłowska, Aleksandra Tołoczko-Grabarek, Jan Lubiński
  • Journal: Hereditary Cancer in Clinical Practice
  • Year: 2021
  • DOI: 10.1186/s13053-020-00161-y

5. Survival of bladder or renal cancer in patients with CHEK2 mutations

  • Authors: Elżbieta Złowocka-Perłowska, Alvaro Galli, Tadeusz Dębniak, Marcin Słojewski, Thierry van de Wetering, Aleksandra Tołoczko-Grabarek, Cezary Cybulski, Rodney J. Scott, Jan Lubiński
  • Journal: PLOS ONE
  • Year: 2021
  • DOI: 10.1371/journal.pone.0257132